Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Jamison, J. Donohue, D. Nagorney, C. Rosen, W. Harmsen, D. Ilstrup (1997)
Hepatic resection for metastatic colorectal cancer results in cure for some patients.Archives of surgery, 132 5
(2013)
Surgeryforcancer : atrigger for metastases
S Hellman, RR Weichselbaum (1995)
OligometastasesJ Clin Oncol, 13
S. Tohme, R. Simmons, A. Tsung (2017)
Surgery for Cancer: A Trigger for Metastases.Cancer research, 77 7
K. Corbin, S. Hellman, R. Weichselbaum (2013)
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 11
(1997)
HarmsenWS, IlstrupDM.Hepatic resection formetastatic colorectal cancer results in cure for some patients
S. Daneshmand, P. Albers, S. Fosså, A. Heidenreich, C. Kollmannsberger, S. Krege, C. Nichols, J. Oldenburg, L. Wood (2012)
Contemporary management of postchemotherapy testis cancer.European urology, 62 5
editorial memo (2018) 11:163–164 https://doi.org/10.1007/s12254-018-0423-z Hannes Kaufmann Received: 10 July 2018 / Accepted: 10 July 2018 / Published online: 17 July 2018 © Springer-Verlag GmbH Austria, part of Springer Nature 2018 One of the principles in oncology over decades was is a relatively new concept and was originally de- that patients diagnosed with metastatic cancer were fined as five or fewer metastatic sites. It was pro- unlikely to be cured of their disease by any means. At posed as a clinically significant state separate from best, treatment with classical chemotherapy ended in the polymetastatic disease [3] and considered to be extended progression-free or overall survival. Com- less aggressive than other metastatic phenotypes [4]. plete remissions from systemic standard chemother- Metastasectomy should be confined to those pa- apy are uncommon, and only a fraction of complete tients groups for whom benefit has been proven, in responders remain progression free for a prolonged particular of discussions according to clinical and period in most malignant diseases. experimental evidence supporting the role of surgery Exceptions of this paradigm according to more and inflammation as potential triggers for disease effective systemic and local treatment strategies are recurrence [5]. Hodgkin disease, some non-Hodgkin lymphomas, Recently
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jul 17, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.